Intestinal smooth muscle cell maintenance by basic fibroblast growth factor

Tissue Engineering - Part A.

Volumn 14, Issue 8, 2008, Pages 1395-1402

  Lee, Min ^a   Wu, Benjamin M ^a   Stelzner, Matthias ^b   Reichardt, Holger M ^c   Dunn, James C Y ^a,b  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BLOOD VESSELS; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELLS; CLADDING (COATING); COLLAGEN; CYTOLOGY; ENCAPSULATION; FIBROBLASTS; HEALTH; MICROSPHERES; PEPTIDES; SCAFFOLDS; TECHNOLOGY; TISSUE; TISSUE ENGINEERING;

ANGIOGENESIS; BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN COATINGS; D ,L-LACTIC-CO-GLYCOLIC ACID; SEEDED CELLS; SHORT BOWEL SYNDROME; SMOOTH MUSCLE ACTIN; SMOOTH MUSCLE CELL; SMOOTH MUSCLE CELL PROLIFERATION; SMOOTH MUSCLE CELLS; SMOOTH MUSCLES; STIMULATE PROLIFERATION; TISSUE-ENGINEERING SCAFFOLDS;

MUSCLE;

ALPHA SMOOTH MUSCLE ACTIN; BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN; MICROSPHERE; POLYGLACTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CELL DENSITY; CELL ENCAPSULATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; FEMALE; IMPLANT; INTESTINE MUSCLE; MUSCLE REGENERATION; NONHUMAN; OMENTUM; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING;

EID: 48749121798     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0232     Document Type: Article

References (34)

1. Thompson, J.S., Iyer, K.R., and Langnas, A.N. Short bowel syndrome and Crohn's disease. J. Gastrointest. Surg. 7, 1069, 2003.
2. Vanderhoof, J.A., and Langnas, A.N. Short bowel syndrome in children and adults. Gastroenterology 113, 1767, 1997.
3. Leaseburge, L.A., Winn, N.J., and Schloerb, P.R. Liver test alteration with TPN and nutritional status. J. Parenter. Enteral. Nutr. 16, 348, 1992.
4. Veenendaal, R.A., Ringers, J., and Lamers, C.B. Clinical aspects of small bowel transplantation. Scand. J. Gastroenterol. 232, 65, 2000.
5. Thompson, J.S. Surgical approach to the short bowel syndrome: procedure to slow intestinal transit. Eur. J. Pediatr. Surg. 9, 263, 1998.
6. Bianchi, A. Intestinal loop lengthening-a technique for increasing small intestinal length. J. Pediatr. Surg. 15, 145, 1980.
7. Organ, G.M., Mooney, D.J., and Hansen, L.K. Transplantation of enterocytes utilizing polymer-cell constructs to produce a neointestine. Transplant. Proc. 24, 3009, 1992.
8. Choi, R.S., Riegler, M., and Vacanti, J.P. Studies of brush border enzymes, basement membrane component, and electrophysiology of tissue engineered neointestine. J. Pediatr. Surg. 33, 991, 1998.
9. Kim, S.S., Kaihara, S., and Vacanti, J.P. Effects of anastomosis of tissue engineered neointestine to native small bowel. J. Surg. Res. 87, 6, 1999.
10. Kaihara, S., Kim, S.S., and Vacanti, J.P. Long-term follow up of tissue engineered intestine after anastomosis to native small bowel. Transplantation 69, 1927, 2000.
11. Chen, M.K., and Badylak, S. Small bowel tissue engineering using small intestinal submucosa as a scaffold. J. Surg. Res. 99, 352, 2001.
12. Hori, Y., Nakamura, T., and Shimizu, Y. Tissue engineering of the small intestine by acellular collagen sponge scaffold grafting. Int. J. Artif. Organs 24, 50, 2001.
13. Hori, Y., Nakamura, T., and Shimizu, Y. Experimental study on tissue engineering of the small intestine by mesenchymal stem cell seeding. J. Surg. Res. 102, 156, 2002.
14. Nakase, Y., Hagiwara, A., Nakamura, T., Kin, S., Nakashima, S., Yoshikawa, T., Fukuda, K., Kuriu, Y., Miyagawa, K., Sakakura, C., Otsuji, E., Shimizu, Y., Ikada, Y., and Yamagishi, H. Tissue engineering of small intestinal tissue using collagen sponge scaffolds seeded with smooth muscle cells. Tissue Eng. 12, 403, 2006.
15. Gospodarowicz, D., and Schweigerer, L. Fibroblast growth factor. Mol. Cell. Endocrinol. 46, 187, 1986.
16. Burgess, W.H., and Maciag, T. Heparin binding fibroblast growth factor family of protein. Annu. Rev. Biochem. 58, 575, 1989.
17. van den Brandt, J., Wang, D., Kwon, S.H., Heinkelein, M., and Reichardt, H.M. Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 39, 94, 2004.
18. Mikos, A.G., Sarakinos, G., Leite, S.M., Vacanti, J.P., and Langer, R. Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials 14, 323, 1993.
19. Eldridge, J.H., Staas, J.K., Tice, T.R., and Gilley, R.M. Biodegradable poly(D,L-lactide-co-glycolide) microspheres. Res. Immunol. 143, 557, 1992.
20. Anderson, J.M., and Shive, M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5, 1997.
21. Lee, M., Chen, T.T., Iruela-Arispe, M.L., Wu, B.M., and Dunn, J.C. Modulation of protein delivery from modular polymer scaffolds. Biomaterials 28, 1862, 2007.
22. Brittingham, J., Phiel, C., Trzyna, W.C., Gabbeta, V., McHugh, K.M. Identification of distinct molecular phenotypes in cultured gastrointestinal smooth muscle cells. Gastroenterology 115, 605, 1998.
23. Kedem, A., Perets, A., Gamlieli-Bonshtein, I., Dvir-Ginzberg, M., Mizrahi, S., Cohen, S. Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng. 11, 715, 2005.
24. Lloyd, D.A.J., Ansari, T.I., Gundabolu, P., Shurey, S., Maquet, V., Sibbons, P.D., Boccaccini A.R., and Gabe, S.M. A pilot study investigating a novel subcutaneously implanted pre-cellularised scaffold for tissue engineering of intestinal mucosa. Eur. Cell Mater. 11, 27, 2006.
25. Belgore, F., Lip, G.Y.H., and Blann, A.D. Basic fibroblast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells. Eur. J. Clin. Invest. 33, 833, 2003.
26. Petrigliano, F.A., English, C.S., Barba, D., Esmende, S., Wu, B.M., and McAllister, D.R. The effects of local bFGF release and uniaxial strain on cellular adaptation and gene expression in a 3D environment: implications for ligament tissue engineering. Tissue Eng. 13, 2721, 2007.
27. Perets, A., Baruch, Y., Weisbuch, F., Shoshany, G., Neufeld, G., and Cohen, S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J. Biomed. Mater. Res. 65, 489, 2003.
28. Kanematsu, A., Yamamoto, S., Ozeki, M., Noguchi, T., Kanatani, I., Ogawa, O., and Tabata, Y. Collagenous matrices as release carriers of exogenous growth factors. Biomaterials 25, 4513, 2004.
29. Ennett, A.B., Kaigler, D., and Mooney, D.J. Temporally regulated delivery of VEGF in vitro and in vivo. J. Biomed. Mater. Res. 79, 176, 2006.
30. Vaughan, M.B., Howard, E.W., and Tomasek, J.J. Transforming growth factor-beta 1 promotes the morphological and functional differentiation of the myofibroblast. Exp. Cell Res. 257, 180, 2000.
31. Chamley-Campbell, J., Campbell, G., and Ross, R. The smooth muscle cell in culture. Physiol. Rev. 59, 1, 1979.
32. Hautmann, M.B., Madsen, C.S., and Owens, G.K. A transforming growth factor beta (TGFb) control element drives TGFβ-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J. Biol. Chem. 18, 10948, 1997.
33. Grainger, D.J., Metcalfe, J.C., Grace, A.A., and Mosedale, D.E. Transforming growth factor beta dynamically regulates vascular smooth muscle differentiation in vivo. J. Cell Sci. 111, 2977, 1998.
34. Zhang, Y., Kropp, B.P., Moore, P., Cowan, R., Furness, P.D., 3rd., Kolligian, M.E., Frey, P., and Cheng, E.Y. Coculture of bladder urothelial and smooth muscle cells on small intestinal submucosa: potential applications for tissue engineering technology. J. Urol. 164, 928, 2000.